The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Mycoplasma Diagnostics Market Research Report 2025
Synopsis
Mycoplasma diagnostics is a class of medical tests or examination conducted to evaluate nucleic acids or proteins at a molecular level. This aids in the early detection of mycoplasma contaminations in samples. Mycoplasma diagnostics is considered as a rapidly evolving and fast growing segment in the in-vitro diagnostic industry. Usually, usage of molecular diagnostics was limited due to necessity of vastly skilled specialists and high cost of tests.
The global Mycoplasma Diagnostics market was valued at US$ 729.9 million in 2023 and is anticipated to reach US$ 1027 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
Based on product, the global mycoplasma diagnostics market can be segmented into kits & reagents, instruments, and software & services. Of these, the kits & reagents segment dominated the market in 2016 and is expected to hold on to its lead through the forecast period. However, growth witnessed in the software & services segment is forecast to be higher in the coming years. The rising demand for automation in pharma, dianostics, and clinical sectors to realize the benefits of cost-effectiveness, will fuel application of mycoplasma diagnostics in these applications.
This report aims to provide a comprehensive presentation of the global market for Mycoplasma Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mycoplasma Diagnostics.
Report Scope
The Mycoplasma Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mycoplasma Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mycoplasma Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Agilent Technologies
Thermo Fisher Scientific
PromoCell
Charles River Laboratories International
Merck KGaA
Lonza Group
Takara Bio (Takara Holding Company.)
Savyon Diagnostics
Tecan Trading (Tecan Group)
Sartorius Stedim BioOutsource
American Type Culture Collection (ATCC)
F Hoffmann-La Roche
Segment by Type
Kits & Reagents
Instruments
Software & Services
Segment by Application
Hospitals
Diagnostic Laboratories
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mycoplasma Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Mycoplasma diagnostics is a class of medical tests or examination conducted to evaluate nucleic acids or proteins at a molecular level. This aids in the early detection of mycoplasma contaminations in samples. Mycoplasma diagnostics is considered as a rapidly evolving and fast growing segment in the in-vitro diagnostic industry. Usually, usage of molecular diagnostics was limited due to necessity of vastly skilled specialists and high cost of tests.
The global Mycoplasma Diagnostics market was valued at US$ 729.9 million in 2023 and is anticipated to reach US$ 1027 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
Based on product, the global mycoplasma diagnostics market can be segmented into kits & reagents, instruments, and software & services. Of these, the kits & reagents segment dominated the market in 2016 and is expected to hold on to its lead through the forecast period. However, growth witnessed in the software & services segment is forecast to be higher in the coming years. The rising demand for automation in pharma, dianostics, and clinical sectors to realize the benefits of cost-effectiveness, will fuel application of mycoplasma diagnostics in these applications.
This report aims to provide a comprehensive presentation of the global market for Mycoplasma Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mycoplasma Diagnostics.
Report Scope
The Mycoplasma Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mycoplasma Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mycoplasma Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Agilent Technologies
Thermo Fisher Scientific
PromoCell
Charles River Laboratories International
Merck KGaA
Lonza Group
Takara Bio (Takara Holding Company.)
Savyon Diagnostics
Tecan Trading (Tecan Group)
Sartorius Stedim BioOutsource
American Type Culture Collection (ATCC)
F Hoffmann-La Roche
Segment by Type
Kits & Reagents
Instruments
Software & Services
Segment by Application
Hospitals
Diagnostic Laboratories
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mycoplasma Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mycoplasma Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Kits & Reagents
1.2.3 Instruments
1.2.4 Software & Services
1.3 Market by Application
1.3.1 Global Mycoplasma Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mycoplasma Diagnostics Market Perspective (2019-2030)
2.2 Mycoplasma Diagnostics Growth Trends by Region
2.2.1 Global Mycoplasma Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Mycoplasma Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Mycoplasma Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Mycoplasma Diagnostics Market Dynamics
2.3.1 Mycoplasma Diagnostics Industry Trends
2.3.2 Mycoplasma Diagnostics Market Drivers
2.3.3 Mycoplasma Diagnostics Market Challenges
2.3.4 Mycoplasma Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mycoplasma Diagnostics Players by Revenue
3.1.1 Global Top Mycoplasma Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Mycoplasma Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Mycoplasma Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Mycoplasma Diagnostics Revenue
3.4 Global Mycoplasma Diagnostics Market Concentration Ratio
3.4.1 Global Mycoplasma Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mycoplasma Diagnostics Revenue in 2023
3.5 Mycoplasma Diagnostics Key Players Head office and Area Served
3.6 Key Players Mycoplasma Diagnostics Product Solution and Service
3.7 Date of Enter into Mycoplasma Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Mycoplasma Diagnostics Breakdown Data by Type
4.1 Global Mycoplasma Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Mycoplasma Diagnostics Forecasted Market Size by Type (2025-2030)
5 Mycoplasma Diagnostics Breakdown Data by Application
5.1 Global Mycoplasma Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Mycoplasma Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Mycoplasma Diagnostics Market Size (2019-2030)
6.2 North America Mycoplasma Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Mycoplasma Diagnostics Market Size by Country (2019-2024)
6.4 North America Mycoplasma Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Mycoplasma Diagnostics Market Size (2019-2030)
7.2 Europe Mycoplasma Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Mycoplasma Diagnostics Market Size by Country (2019-2024)
7.4 Europe Mycoplasma Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mycoplasma Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Mycoplasma Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Mycoplasma Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Mycoplasma Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Mycoplasma Diagnostics Market Size (2019-2030)
9.2 Latin America Mycoplasma Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Mycoplasma Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Mycoplasma Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mycoplasma Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Mycoplasma Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Mycoplasma Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Mycoplasma Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Detail
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies Mycoplasma Diagnostics Introduction
11.1.4 Agilent Technologies Revenue in Mycoplasma Diagnostics Business (2019-2024)
11.1.5 Agilent Technologies Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Mycoplasma Diagnostics Introduction
11.2.4 Thermo Fisher Scientific Revenue in Mycoplasma Diagnostics Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 PromoCell
11.3.1 PromoCell Company Detail
11.3.2 PromoCell Business Overview
11.3.3 PromoCell Mycoplasma Diagnostics Introduction
11.3.4 PromoCell Revenue in Mycoplasma Diagnostics Business (2019-2024)
11.3.5 PromoCell Recent Development
11.4 Charles River Laboratories International
11.4.1 Charles River Laboratories International Company Detail
11.4.2 Charles River Laboratories International Business Overview
11.4.3 Charles River Laboratories International Mycoplasma Diagnostics Introduction
11.4.4 Charles River Laboratories International Revenue in Mycoplasma Diagnostics Business (2019-2024)
11.4.5 Charles River Laboratories International Recent Development
11.5 Merck KGaA
11.5.1 Merck KGaA Company Detail
11.5.2 Merck KGaA Business Overview
11.5.3 Merck KGaA Mycoplasma Diagnostics Introduction
11.5.4 Merck KGaA Revenue in Mycoplasma Diagnostics Business (2019-2024)
11.5.5 Merck KGaA Recent Development
11.6 Lonza Group
11.6.1 Lonza Group Company Detail
11.6.2 Lonza Group Business Overview
11.6.3 Lonza Group Mycoplasma Diagnostics Introduction
11.6.4 Lonza Group Revenue in Mycoplasma Diagnostics Business (2019-2024)
11.6.5 Lonza Group Recent Development
11.7 Takara Bio (Takara Holding Company.)
11.7.1 Takara Bio (Takara Holding Company.) Company Detail
11.7.2 Takara Bio (Takara Holding Company.) Business Overview
11.7.3 Takara Bio (Takara Holding Company.) Mycoplasma Diagnostics Introduction
11.7.4 Takara Bio (Takara Holding Company.) Revenue in Mycoplasma Diagnostics Business (2019-2024)
11.7.5 Takara Bio (Takara Holding Company.) Recent Development
11.8 Savyon Diagnostics
11.8.1 Savyon Diagnostics Company Detail
11.8.2 Savyon Diagnostics Business Overview
11.8.3 Savyon Diagnostics Mycoplasma Diagnostics Introduction
11.8.4 Savyon Diagnostics Revenue in Mycoplasma Diagnostics Business (2019-2024)
11.8.5 Savyon Diagnostics Recent Development
11.9 Tecan Trading (Tecan Group)
11.9.1 Tecan Trading (Tecan Group) Company Detail
11.9.2 Tecan Trading (Tecan Group) Business Overview
11.9.3 Tecan Trading (Tecan Group) Mycoplasma Diagnostics Introduction
11.9.4 Tecan Trading (Tecan Group) Revenue in Mycoplasma Diagnostics Business (2019-2024)
11.9.5 Tecan Trading (Tecan Group) Recent Development
11.10 Sartorius Stedim BioOutsource
11.10.1 Sartorius Stedim BioOutsource Company Detail
11.10.2 Sartorius Stedim BioOutsource Business Overview
11.10.3 Sartorius Stedim BioOutsource Mycoplasma Diagnostics Introduction
11.10.4 Sartorius Stedim BioOutsource Revenue in Mycoplasma Diagnostics Business (2019-2024)
11.10.5 Sartorius Stedim BioOutsource Recent Development
11.11 American Type Culture Collection (ATCC)
11.11.1 American Type Culture Collection (ATCC) Company Detail
11.11.2 American Type Culture Collection (ATCC) Business Overview
11.11.3 American Type Culture Collection (ATCC) Mycoplasma Diagnostics Introduction
11.11.4 American Type Culture Collection (ATCC) Revenue in Mycoplasma Diagnostics Business (2019-2024)
11.11.5 American Type Culture Collection (ATCC) Recent Development
11.12 F Hoffmann-La Roche
11.12.1 F Hoffmann-La Roche Company Detail
11.12.2 F Hoffmann-La Roche Business Overview
11.12.3 F Hoffmann-La Roche Mycoplasma Diagnostics Introduction
11.12.4 F Hoffmann-La Roche Revenue in Mycoplasma Diagnostics Business (2019-2024)
11.12.5 F Hoffmann-La Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
